![Stephen M. Restaino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen M. Restaino
Amministratore Delegato presso Sonosa Medical, Inc.
Posizioni attive di Stephen M. Restaino
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Amministratore Delegato | 01/11/2019 | - |
Fondatore | 01/11/2019 | - |
Storia della carriera di Stephen M. Restaino
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Sonosa Medical, Inc.
![]() Sonosa Medical, Inc. Medical SpecialtiesHealth Technology Sonosa Medical, Inc. is a company that is developing the next generation of tools to diagnose and treat obstructive sleep apnea (OSA). The company is based in Baltimore, MD and was founded by Gilmer L. Blankenship, Stephen M. Restaino, and Jeffrey M. Wolf. OSA is a condition that affects nearly 1 billion people worldwide, causing partial or complete airway collapse during sleep, leading to frequent sleep disruptions and poor sleep quality. Sonosa Medical is developing a wearable ultrasound system to fundamentally change how OSA treatments are managed, providing a direct visual of obstructions during normal sleep, so clinicians can select the right treatment the first time. Stephen M. Restaino has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Stephen M. Restaino
- Esperienza